Transient ischemic attack and stroke in systemic lupus erythematosus (Q38149851)

29 August 2017

Transient ischemic attack and stroke in systemic lupus erythematosus (English)

1 reference

transient cerebral isolation

29 August 2017

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

2

M Petri

1 reference

29 August 2017

H Timlin

1

1 reference

29 August 2017

1 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

22

1 reference

29 August 2017

1251-1258

1 reference

29 August 2017

12

1 reference

A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS

29 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Definition and Evaluation of Transient Ischemic Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

A metaregression analysis of the dose-response effect of aspirin on stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Timing of TIAs preceding stroke: time window for prevention is very short

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Neuroprotective agents for the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Antiphospholipid antibodies and stroke in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Stroke and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Cardiogenic brain embolism and lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Body weight, weight change, and risk for hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Association between smoking and blood pressure: evidence from the health survey for England

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Inflammation, abdominal obesity, and smoking as predictors of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Factors associated with coronary artery calcification in young female patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Optimal use of antimalarials in treating cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Use of atorvastatin in systemic lupus erythematosus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

Probability of stroke: a risk profile from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313497416

21 January 2018

Identifiers

DOI

10.1177/0961203313497416

1 reference

release_okytgbrczrcxnemmksphxw5pvi

29 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/okytgbrczrcxnemmksphxw5pvi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24097997

1 reference

PubMed ID

24097997